Company Search:
Advanced Search
Sponsored Links
Reber Genetics Co Ltd Company Snapshot
Reber Genetics Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Reber Genetics Co Ltd with three other pharmaceutical manufacturers in Asia: Syncore Biotechnology Co Ltd (2016 sales of 6.90 million Taiwanese Dollars [US$236,739.36 ] ), Cho Pharma Inc (1.95 million Taiwanese Dollars [US$66,992.64 ] ), and Body Organ Biomedical Corp (27.52 million Taiwanese Dollars [US$944,555.04 ] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Reber Genetics Co Ltd
  Stock Performance Chart for Reber Genetics Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 11.60
(Figures in Taiwanese Dollars)
1 Week 0.1%   13 Weeks -2.5%  
4 Weeks 5.6%   52 Weeks -66.6%  
Reber Genetics Co Ltd Key Data:
  Ticker: 6479 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 35,024,000
(Year Ending Jan 2017).
Employees: 85
  Currency: Taiwanese Dollars Market Cap: 848,632,800
  Fiscal Yr Ends: December Shares Outstanding: 73,158,000
  Share Type: Gu Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.